radiation retinopathy

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Radiation Retinopathy, Visual Impairment Trial (Faricimab, fluocinolone acetonide)

Not yet recruiting
  • Radiation Retinopathy
  • Visual Impairment
  • (no location specified)
Apr 25, 2023

Radiation Retinopathy Trial in Cleveland (Fluocinolone Acetonide (FA) implant)

Withdrawn
  • Radiation Retinopathy
  • Fluocinolone Acetonide (FA) implant
  • Cleveland, Ohio
    Cole Eye Instiute
Aug 2, 2021

Radiation Retinopathy Trial in United States (0.5 mg ranibizumab, Targeted Retinal Photocoagulation (TRP))

Completed
  • Radiation Retinopathy
  • 0.5 mg ranibizumab
  • Targeted Retinal Photocoagulation (TRP)
  • Dallas, Texas
  • +3 more
Mar 24, 2021

Radiation Retinopathy Trial in Houston, Katy, The Woodlands (Aflibercept)

Active, not recruiting
  • Radiation Retinopathy
  • Houston, Texas
  • +2 more
Dec 7, 2020

Macular Edema, Radiation Retinopathy, Branch Retinal Vein Occlusion Trial in Palo Alto (Episcleral Dexamethasone)

Unknown status
  • Macular Edema
  • +6 more
  • Episcleral Dexamethasone
  • Palo Alto, California
    Stanford Medicine Ophthalmology
Oct 7, 2019

Macular Edema, Cystoid Macular Edema, Uveal Melanoma Trial in Philadelphia (Ozurdex, Bevacizumab)

Terminated
  • Macular Edema
  • +4 more
  • Philadelphia, Pennsylvania
    Ocular Oncology Service, Wills Eye Institute
Aug 29, 2019

Radiation Retinopathy, Macular Edema Trial in Saint Louis, Houston (Aflibercept every 2 months, Aflibercept monthly)

Completed
  • Radiation Retinopathy
  • Macular Edema
  • Aflibercept every 2 months
  • Aflibercept monthly
  • Saint Louis, Missouri
  • +1 more
Apr 24, 2019

Radiation Retinopathy Trial in New York (ranibizumab 2.0 mg)

Completed
  • Radiation Retinopathy
  • ranibizumab 2.0 mg
  • New York, New York
    The New York Eye Cancer Center
Sep 30, 2014

Radiation Retinopathy, Choroidal Melanoma Trial in New York (Ranibizumab, ranibizumab)

Completed
  • Radiation Retinopathy
  • Choroidal Melanoma
  • New York, New York
    The New York Eye Cancer Center
Apr 25, 2012

Uveal Melanoma, Radiation Retinopathy, Radiation Maculopathy Trial in Philadelphia (Ranibizumab)

Unknown status
  • Uveal Melanoma
  • +2 more
  • Philadelphia, Pennsylvania
    Wills Eye Institute
Oct 5, 2007